Risperdal Lawsuit

Risperdal lawsuit

Risperdal is an antipsychotic prescription medication that is manufactured by the Johnson & Johnson subsidiary, Ortho-McNeil-Janssen Pharmaceuticals. The active ingredient in Risperdal is called risperidone. In 2004, Janssen Pharmaceuticals’ risperidone patent expired allowing Teva Pharmaceuticals to manufacture and distribute a generic version of Risperdal. Risperdal was designed for elderly patients to help treat dementia, but tests showed Risperdal could also help children with autism and bipolar disorder. The U.S Food & Drug Administration (FDA) did not approve Risperdal for children until 2006, and more recently Risperdal has been alleged to increase breast tissue in young boys. If you or your child has developed Gynecomastia or increased breast tissue, fill out the form to receive a free case evaluation.

Risperdal lawsuit case review

Risperdal Controversy

There has been a growing concern with the antipsychotic prescription, Risperdal. Risperdal is mainly taken by children or teens for autism, bipolar disorder, or schizophrenia. Risperdal may increase levels of prolactin which is a hormone that stimulates breast development in women. Consequently, this condition causes young boys to develop breast tissue and in some cases experience nipple pain or discharge. The use of Risperdal and growth of breast tissue is a condition in young boys called Gynecomastia. The U.S. Food & Drug Administration has issued several warnings related to Risperdal. Due to growing controversy, Johnson & Johnson has paid billions of dollars to resolve federal allegations and avoid major consequences.

Risperdal Litigation

More than 420 lawsuits have been filed against Johnson & Johnson. Male consumers of Risperdal allege that the manufacturers failed to warn them about the risk of developing breast tissue. Consumers suggest Johnson & Johnson failed to properly research side effects. Johnson & Johnson is also accused of providing monetary incentives to Omnicare, a pharmaceutical supply company, to convince doctors to prescribe Risperdal to patients.

In a Risperdal lawsuit filed in Philadelphia, a young boy claims he began taking Respideral at age 9 in 2000 and continued to take it until 2004. At that time Risperdal was not approved for use by children. According to the claim, concealed or inadequately reported side effects included diabetes mellitus, metabolic syndrome, pancreatitis, hyperprolactinemia, gynecomastia, weight gain, and tardive dyskinesia, among other health risks. Johnson & Johnson was quick to settle with an undisclosed amount of money. Lawsuits against Johnson & Johnson are still being filed and continue to grow in numbers.

Suffering From Gynecomastia?

Have you or a loved one used Risperdal and developed breast tissue? Those suffering from gynecomastia could be eligible to collect compensation for medical expenses, and other damages. For more information on Risperdal lawsuits, fill out our free case review form for a free consultation from a qualified Risperdal attorney.

Show Sources
  1. "J&J Settles Pennsylvania Risperdal Breast Growth Case ." Harris Martin Publishing. (2012): n. page. Print.
  2. "Johnson & Johnson Will Tumble On Risperdal Lawsuit, Bad PR." Seeking Alpha. (2012): n. page. Web. 29 Mar. 2013. http://seekingalpha.com/article/508321-johnson-johnson-will-tumble-on-risperdal-lawsuit-bad-pr
  3. United States. Department of Health and Human Services. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets. Food and Drug Administration, 2011. Print.